Shukla et al. showed that MUC1 and HIF-1α crosstalk mediated an anabolic glucose metabolism reprogramming that increased pyrimidine pools in pancreatic cancer [43]. The gene discussed is HIF1A; the disease is pancreatic neoplasm.